|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Marketable securities | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Receivable from former related party | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Unbilled receivable from related party | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Long-term investments | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Right-of-use operating lease assets | ||||||||||||||||||||
| Other assets and restricted cash | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Current portion of deferred revenue | ||||||||||||||||||||
| Current Portion of Deferred Revenue Related Party | ||||||||||||||||||||
| Current portion of operating lease liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Deferred revenue - related party | ||||||||||||||||||||
| Long-term operating lease liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Convertible preferred stock; $0.0001 par value per share; authorized shares -none and 33,336,283 at December 31, 2023 and 2022, respectively; issued and outstanding - none and 33,336,282 at December 31, 2023 and 2022, respectively; liquidation preference - none and $121,500 at December 31, 2023 and 2022, respectively | ||||||||||||||||||||
| Stockholders' equity/(deficit): | ||||||||||||||||||||
| Preferred stock; $0.001 par value per share; authorized shares - 10,000,000 at June 30, 2026 and December 31, 2025; issued and outstanding - none at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common stock; $0.001 par value per share; authorized shares - 150,000,000 at June 30, 2026 and December 31, 2025; issued and outstanding shares - 54,798,338 and 43,223,090 at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive (loss)/income | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
